MedPath

The clarification of the pathological role of CX3CR1/fractalkine/AIM axis in IgA nephropathy

Not Applicable
Conditions
IgA nephropathy
Registration Number
JPRN-UMIN000011414
Lead Sponsor
Juntendo University, Facility of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
15
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who will transfer to another hospital during the treatment. Patients who already had tonsillectomy or steroid therapy. Patients who already have started immunosuppressant therapy. Patients decided by the doctor to be unsuitable to the study other than above.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hematuria, urinary protein, serum creatinine, estimated GFR
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath